The Crystal Ball of Pharma: Using Patent Expiry Data to Build a More Accurate 3-Year Drug Spend Forecast
In the rapidly evolving landscape of pharmaceutical finance, the ability to accurately forecast drug spending is not just a competitive advantage—it’s a necessity. Yet, for years, pharma companies and payers alike have relied on traditional methods tha…
